Green and black tea for the primary prevention of cardiovascular disease

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Hartley, Louise ^a   Flowers, Nadine ^a   Holmes, Jennifer ^a   Clarke, Aileen ^a   Stranges, Saverio ^a   Hooper, Lee ^b   Rees, Karen ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK TEA EXTRACT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SINECATECHINS; TRIACYLGLYCEROL; TEA;

APPENDICITIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; HUMAN; INFLUENZA; META ANALYSIS; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; RETINA DETACHMENT; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TEA; BEVERAGE; BLOOD; BLOOD PRESSURE; CAMELLIA SINENSIS; CARDIOVASCULAR DISEASES; PHYSIOLOGY; PHYTOTHERAPY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BEVERAGES; BLOOD PRESSURE; CAMELLIA SINENSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; PHYTOTHERAPY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA;

EID: 84891724033     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009934.pub2     Document Type: Review

References (105)

1. Bahorun T, Luximon-Ramma A, Neergheen-Bhujun VS, Gunness TK, Googoolye K, Auger C, et al.The effect of black tea on risk factors of cardiovascular disease in a normal population. Preventive Medicine 2012;54:S98-102.
2. Bahorun T, Luximon-Ramma A, Neergheen-Bhujun VS, Gunness TK, Googoolye K, Auger C, et al.The effect of black tea on risk factors of cardiovascular disease in a normal population. Preventive Medicine 2012;54:S98-102.
3. Bahorun T, Luximon-Ramma A, Neergheen-Bhujun VS, Gunness TK, Googoolye K, Auger C, et al.The effect of black tea on risk factors of cardiovascular disease in a normal population. Preventive Medicine 2012;54:S98-102.
4. Bogdanski P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Green tea extract reduces blood pressure, inflammatory bio markers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutrition Research 2012;32:421-7.
5. Szulinska M, Bogdanski P, Musialik K, Suliburska J. Beneficial influence of green tea extract supplementation on blood pressure, insulin resistance, selected inflammatory markers and total antioxidant status in patients with obesity related hypertension. Obesity Facts 2012;5:197.
6. Fujita H, Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutrition Research 2008;28(7):450-6.
7. Hodgson JM, Puddey IB, Woodman RJ, Mulder TP, Fuchs D, Scott K, et al.Effects of black tea on blood pressure: A randomized controlled trial. Archives of Internal Medicine 2012;172(2):186-8.
8. Janjua R, Munoz C, Gorell E, Rehmus W, Egbert B, Kern D, et al.A two-year, double-blind, randomized placebo-controlled trial of oral Green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin. Dermatological Surgery 2009;35:1057-65.
9. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, et al.Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Archives of Internal Medicine 2003;163(12):1448-53.
10. Mukamal KJ, MacDermott K, Vinson JA, Oyama N, Manning WJ, Mittleman MA. A 6-month randomized pilot study of black tea and cardiovascular risk factors. American Heart Journal 2007;154(4):724.e1-6.
11. Nantz MP, Rowe CA, Bukowski JF, Percival SS. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 2009;25(2):147-54.
12. Shen CL, Chyu MC, Pence BC, Yeh JK, Zhang Y, Felton CK, et al.Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: Safety and quality of life report. BMC Complementary and Alternative Medicine 2010;10(76):1-10.
13. Smith AE, Lockwood CM, Moon JR, Kendall KL, Fukuda DH, Tobkin SE, et al.Physiological effects of caffeine, epigallocatechin-3-gallate, and exercise in overweight and obese women. Applied Physiology, Nutrition and Metabolism 2010;35(5):607-16.
14. Stendell-Hollis NR, Thomson CA, Thompson PA, Bea JW, Cussler EC, Hakim IA. Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. Journal of Human Nutrition and Dietetics 2010;23:590-600.
15. Alexopoulos N, Vlachopoulos C, Aznaouridis K, Baou K, Vasiliadou C, Pietri P, et al.The acute effect of green tea consumption on endothelial function in healthy individuals. European Journal of Cardiovascular Prevention and Rehabilitation 2008;15(3):300-5.
16. Alexopoulos N, Vlachopoulos C, Baou K, Terentes-Printzios D, Aznaouridis K, Ioakeimidis N, et al.The short-term effect of tea consumption on aortic stiffness and wave reflections. Journal of the American College of Cardiology 2009;53(10):A442.
17. Arima M, Yotsumoto Y, Nakamura T, Deuchi K, Hitomi Y, Shioya N, et al.Suppressant effect of black tea polyphenols-enriched black tea beverage on postprandial elevation of blood triglyceride level - A randomized double-blind crossover study. Japanese Pharmacology and Therapeutics 2009;37(6):529-836.
18. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai BO, Auvichayapat N, Thinkhamrop B, et al.Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiology and Behavior 2008;93(3):486-91.
19. Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, Aston CE, et al.Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. Journal of the American College of Nutrition 2010;29(1):31-40.
20. Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, et al.Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2011;27(2):206-13.
21. Batista Gde A, Cunha CL, Scartezini M, von der Heyde R, Bitencourt MG, Melo SF. Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Arquivos Brasileiros de Cardiologia 2009;93(2):128-34.
22. Belza A, Toubro S, Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. European Journal of Clinical Nutrition 2009;63(1):57-64.
23. Bingham SS, Vorster H, Jerling JC, Magee E, Mulligan A, Runswick SA, et al.Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. British Journal of Nutrition 1997;78(1):41-55.
24. Brown AL, Lane J, Holyoak C, Nicol B, Mayes AE, Dadd T. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. British Journal of Nutrition 2011;106(12):1880-9.
25. Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, et al.Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. Journal of Nutrition 2003;133:3298S-302S.
26. de Maat MP, Pijl H, Kluft C, Princen HM. Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. European Journal of Clinical Nutrition 2000;54:757-63.
27. Di Pierro F, Menghi AB, Barreca A, Lucarelli M, Calandrelli A. Greenselect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Alternative Medicine Review 2009;14(2):154-60.
28. Eichenberger P, Mettler S, Arnold M, Colombani PC. No effects of three-week consumption of a green tea extract on time trial performance in endurance-trained men. International Journal for Vitamin and Nutrition Research 2010;80(1):54-64.
29. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. The Journal of Nutritional Biochemistry 2005;16:144-9.
30. Fisunoglu M, Besler HT. Effects of regular black tea consumption on the antioxidant activity. FASEB 2010;24:921.1.
31. Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JPE, Minihane AM, et al.Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. Journal of Nutrition 2009;139(1):58-62.
32. Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, et al.Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. European Journal of Nutrition 1999;38:149-57.
33. Gordillo-Bastidas E, Yanez-Sanchez I, Panduro A, Martinez-Lopez E. Effect of moderate-fat diet complemented with green tea on anthropometric and biochemical markers, and cardiovascular risk in obese patients. Diabetes and Vascular Disease Research 2011;8(1):83-4.
34. Grassi D, Mulder TP, Draijer R, Desideri G, Molhuizen HO, Ferri C. Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. Journal of Hypertension 2009;27(4):774-81.
35. Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S, et al.Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. Journal of Nutrition 2003;133(10):3303S-9S.
36. Hirata K, Shimada K, Watanabe H, Otsuka R, Tokai K, Yoshiyama M. Black tea increases coronary flow velocity reserve in healthy male subjects. American Journal of Cardiology 2004;93(11):1384-8.
37. Hodgson JM, Puddey IB, Burke V, Beilin LJ, Jordan N. Effects on blood pressure of drinking green and black tea. Journal of Hypertension 1999;17(4):457-63.
38. Hodgson JM, Puddey IB, Croft KD, Burke V, Mori TA, Caccetta RA, et al.Acute effects of ingestion of black and green tea on lipoprotein oxidation. The American Journal of Clinical Nutrition 2000;71:1103-7.
39. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. European Journal of Clinical Nutrition 2001;55:881-6.
40. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ. Regular ingestion of black tea improves brachial artery vasodilator function. Clinical Science 2002;102(2):195-201.
41. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, Puddey IB. Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. Journal of Nutrition 2002;132(1):55-8.
42. Hodgson JM, Puddey IB, Burke V, Beilin LJ, Mori TA, Chan SY. Acute effects of ingestion of black tea on postprandial platelet aggregation in human subjects. British Journal of Nutrition 2002;87:141-5.
43. Hodgson JM, Burke V, Beilin LJ, Croft KD, Puddey IB. Can black tea influence plasma total homocysteine concentrations?. American Journal of Clinical Nutrition 2003;77(4):907-11.
44. Inami S, Takano M, Yamamoto M, Murakami D, Tajika K, Yodogawa K, et al.Tea catechin consumption reduces circulating oxidized low-density lipoprotein. International Heart Journal 2007;48(6):725-32.
45. Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, et al.Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. American Journal of Clinical Nutrition 1997;66(2):261-6.
46. Kurita I, Maeda-Yamamoto M, Tachibana H, Kamei M. Antihypertensive effect of Benifuuki tea containing O-methylated EGCG. Journal of Agricultural & Food Chemistry 2010;58(3):1903-8.
47. Miller RJ, Jackson KG, Dadd T, Mayes AE, Brown AL, Lovegrove JA, et al.The impact of the catechol-O-methyltransferase genotype on vascular function and blood pressure after acute green tea ingestion. Molecular Nutrition & Food Research 2012;56(6):966-75.
48. Muroyama K, Yamamoto N. Evaluations of the effectiveness of tea containing thiamin, arginine, caffeine and citric acid on moderately obese subjects with visceral obesity and its safety. Japanese Pharmacology and Therapeutics 2006;34(10):1097-105.
49. Nagaya N, Yamamoto H, Uematsu M, Itoh T, Nakagawa K, Miyazawa T. Green tea reverses endothelial dysfunction in healthy smokers. Heart 2004;90(12):1485-6.
50. Penugonda K, Sanchez K, Leyva M, Aston C, Lyons T, Basu A. Effect of green tea flavonoid supplementation on features of metabolic syndrome (MeS). FASEB 2009;23:S1.
51. Pricen HM, Van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LBM, Langius JAE, et al.No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arteriosclerosis, Thrombosis, and Vascular Biology 1998;18:833-41.
52. Quinlan P, Lane J, Aspinall L. Effects of hot tea, coffee and water ingestion on physiological responses and mood: The role of caffeine, water and beverage type. Psychopharmacology 1997;134(2):164-73.
53. Quinlan PT, Lane J, Moore KL, Aspen J, Rycroft JA, O'Brien DC. The acute physiological and mood effects of tea and coffee: the role of caffeine level. Pharmacology, Biochemistry & Behavior 2000;66(1):19-28.
54. Rakic V, Beilin LJ, Burke V. Effect of coffee and tea drinking on postprandial hypotension in older men and women. Clinical and Experimental Pharmacology and Physiology 1996;23(6-7):559-63.
55. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, et al.Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Research and Clinical Practice 2006;71:833-41.
56. Schmidschonbein H, Zollenkopf G, Michaelis P. Hemorheological effects of common drinks - Comparison between mineral waters containing NaCl and drinks which are low on mineral content (Black tea, Apple tea). Nieren-Und Hochdruckkrankheiten 1991;20(10):601-5.
57. Schultz V. Green tea extract for weight reduction? Randomized double blind study cannot confirm positive preliminary results. Zeitschrift fur Phytotherapie 2009;30(2):74-5.
58. Steptoe A, Gibson EL, Vuononvirta R, Williams ED, Hamer M, Rycroft JA, et al.The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial. Psychopharmacology 2007;190(1):81-9.
59. Takase H, Nagao T, Otsuka K, Meguro S, Komikado M, Tokimitsu T. Effects of long-term ingestion of tea catechins on visceral fat accumulation and metabolic syndrome risk in women with abdominal obesity. Japanese Pharmacology and Therapeutics 2008;36(3):237-45.
60. Takeshita M, Takashima S, Harada U, Shibata E, Hosoya N, Takase, H, et al.Effects of long-term consumption of tea catechins-enriched beverage with no caffeine on body composition in humans. Japanese Pharmacology and Therapeutics 2008;36(8):767-76.
61. Trautwein EA, Du Y, Meynen E, Yan X, Wen Y, Wang H, et al.Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. European Journal of Nutrition 2010;49(1):27-35.
62. Unno T, Tago M, Suzuki Y, Nozawa A, Sagesaka YM, Kakuda T, et al.Effect of tea catechins on postprandial plasma lipid responses in human subjects. British Journal of Nutrition 2005;93:543-7.
63. Vlachopoulos C, Alexopoulos N, Dima I, Aznaouridis K, Andreadou I, Stefanadis C. Acute effect of black and green tea on aortic stiffness and wave reflections. Journal of the American College of Nutrition 2006;25:216-23.
64. Wang H, Wen Y, Du Y, Yan X, Guo H, Rycroft JA, et al.Effects of catechin enriched green tea on body composition. Obesity 2010;18(4):773-9.
65. Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prevention Research 2012;5(3):393-402.
66. Yen YH. Supplement containing Camellia sinensis (green tea) may help treat obesity. Focus on Alternative and Complementary Therapies 2010;15(1):15-6.
67. Yoshikawa T, Yamada H, Matsuda K. Effects of short-term consumption of a large amount of tea catechins on chromosomal damage, oxidative stress markers, serum lipid, folic acid, and total homocysteine levels: A randomized, double-blind, controlled study. Japanese Journal of Clinical Pharmacology and Therapeutics 2012;43(1):9-16.
68. Chen WF, Lin QC. Combined hypertensive tea in the treatment of hypertension. Chung Hsi i Chieh Ho Tsa Chih Chinese Journal of Modern Developments in Traditional Medicine 1991;11(2):100-1.
69. Lu Q, Zhang WX. Clinical observation of tea pigment on degrading hyperlipoidemia and hyperfibrinogen. Forum on Traditional Chinese Medicine 1997;12(4):36.
70. Mitsuhiro Yamada. A randomized, double-blind, placebo-controlled study of effect of green tea on lifestyle-related disease prevention. JPRN-UMIN000001722: http://apps.who.int/trialsearch/trial.aspx?trialid=JPRN-UMIN000001722 28/5/12.
71. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009;40:1786-92.
72. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Cat. no. PHE 82. Canberra: AIHW 2007.
73. British Heart Foundation 2012. Cardiovascular Disease. http://www.bhf.org.uk/heart-health/conditions/cardiovascular-disease.aspx (Accessed April 2012).
74. Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pedoe H. Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. Journal of Epidemiology and Community Health 1993;47:171-5.
75. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, et al.Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. British Journal of Nutrition 2009;101(6):886-94.
76. Corradini E, Foglia P, Giansanti P, Gubbiotti R, Samperi R, Lagana A. Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants. Natural Product Research 2011;25:469-95.
77. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, et al.Tea and coffee consumption and cardiovascular morbidity and mortality. Arteriosclerosis, Thrombosis, and Vascular Biology 2010;30(8):1665-71.
78. Deka A, Vita J. Tea and cardiovascular disease. Pharmacological Research 2011;64:136-45.
79. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(7109):629-34.
80. Ellinger S, Muller N, Stehle P, Ulrich-Merzenich G. Consumption of green tea or green tea products: is there an evidence for antioxidant effects from controlled interventional studies?. Phytomedicine 2011;18(11):903-15.
81. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. European Heart Journal 2004;25(6):484-91.
82. Gardner EJ, Ruxton CHS, Leeds AR. Black tea - helpful or harmful? A review of the evidence. European Journal of Clinical Nutrition 2007;61:3-8.
83. He F, Burnier M, MacGregor G. Nutrition in cardiovascular disease: salt in hypertension and heart failure. European Heart Journal 2011;32:3073-80.
84. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. Antioxidantavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. American Journal of Clinical Nutrition 1997;65:1489-94.
85. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of interventions Version 5.1 [updated March 2011]. The Cochrane Library, The Cochrane Collaboration (2011). Available from www.cochrane-handbook.org.
86. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al.Flavonoids, flavonoid-rich foods and cardiovascular risk: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 2008;88:38-50.
87. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, et al.Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. The American Journal of Medicine 2002;113(Suppl. 9B):71S-88S.
88. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. Journal of Nutrition 2008;138:1548S-53S.
89. Mackay J, Manesh GA. The Atlas of Heart Disease and Stroke. Geneva: WHO 2004.
90. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C et al. JACC study Group. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. Journal of Epidemiology and Community Health 2010;65:230-40.
91. Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011;124:2145-54.
92. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 2007;15(6):1473-83.
93. NHS, 2010. Atherosclerosis. http://www.nhs.uk/conditions/Atherosclerosis/Pages/Introduction.aspx#commentCountLink (Accessed April 2012).
94. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al.Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515.
95. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. American Journal of Epidemiology 2001;154(6):495-503.
96. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. American Journal of Clinical Nutrition 2005;81(Suppl):215S-7S.
97. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardial infarction. American Journal of Epidemiology 1999;149(2):162-7.
98. Shukla Y. Tea and cancer chemoprevention. A comprehensive review. Asian Pacic Journal of Cancer Prevention 2007;8:155-6.
99. Siri-Tarino P, Sun Q, Hu F, Krauss R. Saturated fat, carbohydrate, and cardiovascular disease. American Journal of Clinical Nutrition 2010;91:502-9.
100. Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role of inammation in atherosclerosis. Journal of Nuclear Medicine 2007;48(11):1800-15.
101. Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Molecular, Nutrition and Food Research 2006;50:218-28.
102. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology 2000;53:1119-29.
103. Sterne JA, Egger M, Smith GD. Systematic reviews in health care:investigating and dealing with publication and other biases in meta analysis. BMJ 2001;323:101-5.
104. World Health Organization. Cardiovascular diseases (CVDs). September 2011; Fact Sheet Number 317.
105. WHO. The World health report: 2003: shaping the future. The World Health Organization. Switzerland, 2003.